Overdose Deaths Increased in Pregnant and Postpartum Women from Early 2018 to Late 2021

News
- Aug 4
Senate Appropriators Advance Modest Substance Use, Mental Health Block Grant Increases in Spending B
- Aug 4
SAMHSA Issues Advisory on Digital Therapeutics in Behavioral Health
- Jul 17
One Year Anniversary of 988 Suicide and Crisis Lifeline

- Jul 11
Op Ed: What Does It Means To Be 'In Recovery'? We Need a Better Federal Definition.
- Jun 30
CDC Releases New Overdose Prevention and Surveillance Resources

- Jun 13
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
- Jun 13
SAMHSA Data Released on Lesbian, Gay, and Bisexual Behavioral Health

- Jun 12
NIH, FDA Call for Lower Barriers to Improve and Implement Drug-Checking Tools

- May 30
Study Finds Inherited Genetic Signature Linked to Increased Risk for Addiction


- Mar 31
FDA APPROVES OVER-THE-COUNTER NALOXONE

- Mar 31
NEW STUDY REVEALS SHARED GENETIC MARKERS UNDERLYING SUBSTANCE USE DISORDERS
- Mar 31
SAMHSA WARNS OF GROWING THREAT FROM XYLAZINE
- Mar 31
DEA ISSUES ALERT ON RISE OF FENTANYL MIXED WITH XYLAZINE


- Mar 31
U.S.-LED GLOBAL EFFORT HAS DRAMATICALLY INCREASED NUMBER RECEIVING LIFESAVING HIV TREATMENT
- Mar 31
NALOXONE EXPANSION NOT ASSOCIATED WITH INCREASES IN ADOLESCENT HEROIN AND INJECTION DRUG USE
- Mar 31
STUDY SHOWS HIGH PREVALENCE OF BUPRENORPHINE 'SPIKING' IN URINE SCREENINGS FOR OUD PATIENTS
- Mar 24
STUDY SUGGESTS HIGH-DOSE BUPRENORPHINE IS USEFUL AMONG PATIENTS USING FENTANYL AND OTHER OPIOIDS
- Mar 24
HOUSE MEMBERS FORM BIPARTISAN FENTANYL PREVENTION CAUCUS
- Mar 24
BIPARTISAN SENATE GROUP INTRODUCES LEGISLATION TO CRACK DOWN ON XYLAZINE